(SRCL) Stericycle - Ratings and Ratios

Stericycle, Inc. is a leader in regulated waste and compliance services, operating across the United States, Europe, and international markets. The company provides a comprehensive suite of services, including regulated medical waste management, sharps disposal, pharmaceutical waste disposal, and chemotherapy waste management. It also offers specialty services like MedDrop medication collection kiosks, SafeDrop sharps mailback solutions, and waste management for airports and maritime operations. Additionally, Stericycle operates a medical supply store, offering sharps containers, infection control supplies, and mail-back solutions for medications. Its compliance solutions include Steri-Safe programs tailored for healthcare providers. Beyond waste management, the company provides secure document and hard drive destruction services under the Shred-it brand.

Stericycle serves a diverse range of industries, including healthcare facilities such as hospitals, physician offices, and long-term care centers; airports and seaports; education institutions; funeral homes; government and military entities; and financial institutions. The company was founded in 1989 and is headquartered in Bannockburn, Illinois. As of November 4, 2024, Stericycle operates as a subsidiary of Waste Management, Inc. Its services are critical to ensuring regulatory compliance and environmental safety for its clients.

Based on the provided and , here is a 3-month forecast for Stericycle, Inc. (NASDAQ:SRCL):

Short-Term (Next 30 Days): - The stock is likely to trade within a range of $82.38 to $92.42, based on its ATR of 4.52 and current price of $87.90. - The SMA 20 ($85.81) and SMA 50 ($86.07) indicate near-term support levels. A breakout above $90 could signal upward momentum. - The stock is trading above its SMA 200 ($71.99), suggesting a bullish long-term trend. - Average volume of 219,445 shares suggests moderate liquidity, which may impact intraday price movements.

Medium-Term (30-60 Days): - The stock may test resistance at $92.42 (SMA 50 + 2*ATR) and $94.34 (SMA 20 + 2*ATR). - Support levels at $82.38 (SMA 200 - 2*ATR) and $84.29 (SMA 50 - 2*ATR) are critical for maintaining the uptrend. - The P/S ratio of 2.19 suggests the stock is fairly valued relative to its revenue, which may attract value investors.

Long-Term (60-90 Days): - With a forward P/E of 22.37, the stock is priced for growth, though the current P/E of 158.92 reflects elevated valuations. - The company’s acquisition by Waste Management, Inc. could lead to operational synergies, potentially driving long-term value. - The RoE of 0.79 indicates moderate profitability, which may improve with integration into Waste Management’s infrastructure.

Overall, Stericycle is well-positioned to benefit from increasing demand for regulated waste and compliance services, particularly in the healthcare sector. While short-term price movements may be volatile, the stock’s long-term outlook remains stable, supported by its essential services and strategic acquisition.